The FDA is preparing testing and manufacturing guidelines for a quick review of Omicron-targeted vaccines and drugs, if they are needed
The Food and Drug Administration is laying the groundwork for the rapid review ofif they turn out to be needed, according to people familiar with the matter.
The agency, building on rules established earlier this year to assess shots and treatments, has been meeting with drugmakers and setting guidelines for the studies and data needed to swiftly evaluate products targeting the new Omicron Covid-19 variant, the people said.
Brasil Últimas Notícias, Brasil Manchetes
Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.
Company stops selling baby-monitoring smart socks after FDA warningA line of baby-monitoring socks, marketed to measure a baby's vital signs while they sleep, has been discontinued after a warning from the FDA.
Consulte Mais informação »
Factbox: What COVID-19 vaccine and drug makers have to say about OmicronThe Omicron variant of the coronavirus has sparked fears that existing COVID-19 vaccines and treatment could be less effective against it.
Consulte Mais informação »
Live updates: Omicron Covid-19 variant puts world on edgeScientists are racing to determine the Omicron coronavirus variant's severity, transmissibility and whether it evades current vaccines. Follow here for the latest news.
Consulte Mais informação »
Germany announces new restrictions banning unvaccinated people from non-essential public spacesScientists are racing to determine the Omicron coronavirus variant's severity, transmissibility and whether it evades current vaccines. Follow here for the latest news.
Consulte Mais informação »
Dow Rebounds Over 600 Points Despite Second U.S. Omicron CaseThe Dow rebounds over 600 points despite the second U.S. omicron case by skleb1234
Consulte Mais informação »
British drug firm claims its antibody vaccine works against OmicronBritish drugmaker GlaxoSmithKline says its Covid-19 antibody drug appears to be effective against the Omicron variant, based on initial laboratory testing
Consulte Mais informação »